About Index Trending news
Analyze
Top 50 Pricing
Virobay

Virobay

Work at Virobay? Add yourself to this profile

Virobay

Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases and cancer.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$10,000,000
Debt financing
$300,000
Employees

Unknown size

Locations

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Virobay makes some noise.